4//SEC Filing
ANDRZEJEWSKI STEPHEN J 4
Accession 0001209191-09-010529
CIK 0001047699other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 7:13 PM ET
Size
6.2 KB
Accession
0001209191-09-010529
Insider Transaction Report
Form 4
ANDRZEJEWSKI STEPHEN J
Chief Commercial Officer
Transactions
- Award
Long-Term Performance Unit
2009-02-17+39,000→ 39,000 totalExp: 2010-12-31→ Common Stock (39,000 underlying)
Footnotes (3)
- [F1]Each Long-Term Performance Unit represents a contingent right to receive one share of King Pharmaceuticals, Inc. common stock.
- [F2]The number of Long-Term Performance Units awarded was based on the achievement of certain 2008 annual earnings per share targets established in early 2008.
- [F3]The Long-Term Performance Units vest in full on December 31, 2010, contingent upon the reporting person's continuing to be employed by King Pharmaceuticals, Inc. as of that date.
Documents
Issuer
KING PHARMACEUTICALS INC
CIK 0001047699
Entity typeother
Related Parties
1- filerCIK 0001321648
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 7:13 PM ET
- Size
- 6.2 KB